| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $573.3M | +11.9% |
| Cost of Revenue | $185.1M | +0.5% |
| Gross Profit | $388.2M | +18.3% |
| R&D Expense | $13.6M | +1.4% |
| SG&A Expense | $340.9M | +12.2% |
| Operating Income | -$12.0M | +85.3% |
| Pre-tax Income | -$49.1M | +59.4% |
| Income Tax | -$5.3M | -6327.1% |
| Net Income | -$33.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.6M | +12.5% |
| Accounts Receivable | $127.4M | +3.7% |
| Inventory | $92.5M | +1.3% |
| Current Assets | $275.6M | +2.8% |
| Total Assets | $728.0M | -10.2% |
| Current Liabilities | $210.4M | +19.9% |
| Long-term Debt | $308.3M | -16.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $38.8M | +152.8% |
| Capital Expenditures | $1.0M | -86.3% |
| Investing Cash Flow | $23.0M | +45.3% |
| Financing Cash Flow | -$54.6M | -104.8% |
| Free Cash Flow | $37.8M | +373.4% |
| +78.5% |
| EPS (Basic) | -$0.52 | +79.1% |
| EPS (Diluted) | -$0.52 | +79.1% |
| Total Liabilities |
| $542.4M |
| -8.0% |
| Stockholders' Equity | $147.9M | -14.8% |